Market Size of Neuroendoscopy Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 3.27 Billion |
Market Size (2029) | USD 4.25 Billion |
CAGR (2024 - 2029) | 5.37 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Neuroendoscopy Market Analysis
The Neuroendoscopy Market size is estimated at USD 3.27 billion in 2024, and is expected to reach USD 4.25 billion by 2029, growing at a CAGR of 5.37% during the forecast period (2024-2029).
The neuroendoscopes market has been moderately impacted by the COVID-19 pandemic. These devices are used for the treatment of conditions of the central nervous system. As elective surgeries have been postponed, neuroendoscopes have been less utilized than usual and thus suffer from less investment than usual as well. Even as elective procedures resume, it is likely that patients will not attend their delayed screening due to nervousness from the crisis. The neuroendoscopes market suffered from less demand throughout 2020, though revenue rose in 2021 as delayed elective procedures were completed, and vaccines helped patients feel safer about completing screenings.
Neuroendoscopy is performed using an endoscope on end to allow the neurosurgeon to navigate and access the tumor. In order to remove a tumor or take a sample of it (a biopsy), neurosurgeons attach special instruments to the endoscope, often an additional endoscope with forceps and scissors on end, as opposed to conventional open brain surgery, which requires more time for healing post-surgery and induces less pain. Also, neuroendoscopic procedures cause minimal scarring in patients. These benefits are being considered widely in the medical community, and therefore, these procedures are becoming more common worldwide. Hence, the benefits of neuroendoscopic surgery over conventional brain surgery are expected to drive the growth of the market. Other factors that will affect the growth of this market include the rising prevalence of neurological disorders and favorable government initiatives.
Neuroendoscopy Industry Segmentation
As per the scope of the report, neuroendoscopy is a minimally invasive surgical procedure in which the neurosurgeon removes the tumor through small holes in the skull or through the mouth or nose. The neuroendoscopy market is segmented by product (rigid neuroendoscopes and flexible neuroendoscopes), application (transnasal neuroendoscopy, intraventricular neuroendoscopy, and transcranial neuroendoscopy), usability (reusable neuroendoscopes and disposable neuroendoscopes), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
By Product | |
Rigid Neuroendoscopes | |
Flexible Neuroendoscopes |
By Application | |
Transnasal Neuroendoscopy | |
Intraventricular Neuroendoscopy | |
Transcranial Neuroendoscopy |
By Usability | |
Reusable Neuroendoscopes | |
Disposable Neuroendoscopes |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Neuroendoscopy Market Size Summary
The neuroendoscopy market is poised for significant growth over the forecast period, driven by the increasing adoption of neuroendoscopic procedures due to their advantages over conventional brain surgery. These procedures, which involve the use of an endoscope to navigate and access tumors, offer benefits such as reduced healing time, less pain, and minimal scarring, making them increasingly popular in the medical community. The market is also supported by the rising prevalence of neurological disorders and favorable government initiatives. The demand for flexible neuroendoscopes, which provide enhanced visibility and can navigate curved trajectories, is expected to rise due to their technological advancements and effectiveness in treating conditions like chronic subdural hematoma and purulent intracranial infections. The presence of innovative products, such as the FDA-approved flexible video neuroendoscope by Karl Storz GmbH, further bolsters market growth prospects.
North America currently leads the neuroendoscopy market, driven by factors such as the increasing prevalence of neurological disorders and a growing preference for minimally invasive surgeries. The region's dominance is supported by the rising geriatric population and the associated risk of neurodegenerative diseases, as well as the incidence of brain tumors. The market is also benefiting from technological advancements and new product approvals, such as the Axonpen System by ClearMind Biomedical. Global players like Adeor Medical AG, B. Braun Melsungen AG, and KARL STORZ SE & Co. KG are key contributors to the market's expansion. Strategic partnerships, such as the one between ClearPoint Neuro Inc. and Adeor Medical AG, are expected to further enhance market dynamics, ensuring continued growth and innovation in the neuroendoscopy sector.
Neuroendoscopy Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Neurological Disorders
-
1.2.2 Benefits of Neuroendoscopic Surgery over Conventional Brain Surgery
-
1.2.3 Favorable Government Initiatives
-
-
1.3 Market Restraints
-
1.3.1 High Cost of the Procedures
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 Rigid Neuroendoscopes
-
2.1.2 Flexible Neuroendoscopes
-
-
2.2 By Application
-
2.2.1 Transnasal Neuroendoscopy
-
2.2.2 Intraventricular Neuroendoscopy
-
2.2.3 Transcranial Neuroendoscopy
-
-
2.3 By Usability
-
2.3.1 Reusable Neuroendoscopes
-
2.3.2 Disposable Neuroendoscopes
-
-
2.4 By Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Neuroendoscopy Market Size FAQs
How big is the Neuroendoscopy Market?
The Neuroendoscopy Market size is expected to reach USD 3.27 billion in 2024 and grow at a CAGR of 5.37% to reach USD 4.25 billion by 2029.
What is the current Neuroendoscopy Market size?
In 2024, the Neuroendoscopy Market size is expected to reach USD 3.27 billion.